ANVS

Annovis Bio Inc

Healthcare · Biotechnology

0.8533$ -2.4% vs. previous close Closing price · As of: Nov 11, 2026

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Annovis Bio Inc (ANVS) with date, type and a link to the original document.

Filings ANVS
Date	Type	Filing	Original
11/05/2026	Current report (8-K)	Annovis Bio, Inc. (ANVS): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits	View report ↗
11/05/2026	Capital measure	Form 424B5 filed with the SEC	View document ↗
11/04/2026	Current report (8-K)	Annovis Bio, Inc. (ANVS): Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events	View report ↗
11/04/2026	Current report (8-K)	Annovis Bio, Inc. (ANVS): Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits	View report ↗
11/04/2026	Capital measure	Form 424B5 filed with the SEC	View document ↗
10/30/2026	Current report (8-K)	Annovis Bio, Inc. (ANVS): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Regulation FD Disclosure; Financial Statements and Exhibits	View report ↗
10/19/2026	Current report (8-K)	Annovis Bio, Inc. (ANVS): Other Events; Financial Statements and Exhibits	View report ↗
08/14/2026	Current report (8-K)	Annovis Bio, Inc. (ANVS): Results of Operations and Financial Condition; Financial Statements and Exhibits	View report ↗
08/14/2026	Ownership disclosure	Form SC 13G filed with the SEC	View document ↗

Showing the 100 most recent filings of the selected type.

Data as of: November 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Filings

Cookie settings